Halma plc logo

Halma plc (HLMA)

Market Closed
12 Jun, 15:30
LSE LSE
3,898. 00
GBX
-30
-0.7637%
GBX
12.9B Market Cap
- P/E Ratio
0.42% Div Yield
2.9M Volume
0 Eps
3,928 GBX
Previous Close
Add Transaction
Day Range
3,898 4,096
Year Range
3,078 4,902
Want to track HLMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HLMA closed today lower at 3,898 GBX, a decrease of -0.7637% from yesterday's close, completing a monthly decrease of -10.9029% or -477 GBX. Over the past 12 months, HLMA stock gained 9.6175%.
HLMA pays dividends to its shareholders, with the most recent payment made on Jan 30, 2026. The next announced payment will be in In 2 months on Aug 14, 2026 for a total of 15.11 GBX.
The last earnings report, released on Jun 11, 2026, missed the consensus estimates by -0.5502%. On average, the company has fell short of earnings expectations by -0.1834%, based on the last three reports.
Halma plc has completed 5 stock splits, with the recent split occurring on Aug 11, 1997.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on LSE (GBX).

HLMA Chart

People also search for

Skanska AB (publ) ser. B
kr 239.6
+1.8708%
Trelleborg AB (publ) Series B shares
kr 408.1
+0.6909%
SKF AB Class B shares
kr 238
+0.6768%
Saab AB (publ) Class B
kr 523.2
-3.129%
Lifco AB (publ) Class B
kr 306.8
+0.9875%

Halma plc (HLMA) FAQ

What is the stock price today?

The current price is 3,898.00 GBX.

On which exchange is it traded?

Halma plc is listed on LSE.

What is its stock symbol?

The ticker symbol is HLMA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.42%.

What is its market cap?

As of today, the market cap is 12.9B.

Has Halma plc ever had a stock split?

Halma plc had 5 splits and the recent split was on Aug 11, 1997.

Halma plc Profile

Industrial Conglomerates Industry
Industrials Sector
Marc Arthur Ronchetti CEO
LSE Exchange
G42504103 CUSIP
GB Country
8,000 Employees
9 Jul 2026 Last Dividend
11 Aug 1997 Last Split
- IPO Date

Overview

Halma plc is a diversified technology company primarily operating in the safety, health, and environmental markets. With its foundation dating back to 1894, it has grown to deliver a wide array of technology solutions globally. The company navigates through its mission with a clear focus on three core segments: Safety, Environmental & Analysis, and Medical. Each segment caters to a specific set of needs, from protecting people and assets to ensuring environmental sustainability and advancing health care. Headquartered in Amersham, the United Kingdom, Halma demonstrates a commitment to innovation, life protection, and improving the quality of life through its numerous subsidiaries spread across different markets.

Products and Services

  • Safety Segment

    This segment contributes to a safer world through an array of technologies, including fire detection systems, specialist fire suppression, elevator safety, and explosion protection. Notable products include security sensors, people and vehicle flow technologies, and specialized interlocks for controlling critical processes safely. Markets served include fire suppression, elevator safety, industrial access control, and more, emphasizing Halma’s commitment to protecting assets and ensuring industrial safety.

  • Environmental & Analysis Segment

    Halma's focus on environmental sustainability is evident in its Environmental & Analysis segment, offering products such as optical, optoelectronic, and spectral imaging systems. Additionally, it provides technologies for monitoring water, air, and gases alongside instruments for detecting hazardous gases and analyzing air quality. Systems for water analysis and treatment also play a crucial role, serving essential markets like optical analysis, environmental monitoring, and gas detection, thereby supporting global efforts in environmental conservation and safety.

  • Medical Segment

    This segment is dedicated to advancing healthcare through a variety of technologies and solutions. It includes critical fluidic components for medical diagnostics, laboratory devices, and systems that assist in patient health understanding. Halma also offers technologies to facilitate in-vitro diagnostic systems, life-science research, and therapeutic solutions across clinical specialties. Serving the life sciences, health assessment, and therapeutic solutions market, this segment showcases Halma’s dedication to enhancing healthcare outcomes and enabling discoveries in medicine.

Contact Information

Address: Misbourne Court
Phone: 44 1494 721111